RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
June 06, 2025 16:07 ET Â | Source: Restem MIAMI, June 06, 2025…
Enovis to Participate in Upcoming Investor Conferences
June 06, 2025 16:05 ET Â | Source: Enovis Corporation Wilmington, DE, June…
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025 16:05 ET Â | Source: TELA Bio, Inc. MALVERN, Pa.,…
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 06, 2025 16:05 ET  | Source: PolyPid Ltd. PETACH TIKVA, Israel, June…
IDEX Biometrics ASA: New date for the share consolidation and ISIN change
June 06, 2025 12:30 ET Â | Source: IDEX BIOMETRICS ASA Reference is…
Xilio Therapeutics Announces Closing of $50.0 Million Public Offering
June 05, 2025 18:38 ET Â | Source: Xilio Therapeutics, Inc. Total gross…
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes
June 05, 2025 17:35 ET Â | Source: DENTSPLY SIRONA Inc. CHARLOTTE, N.C.,…
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025 16:58 ET Â | Source: Boundless Bio, Inc. SAN DIEGO,…
ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)
June 05, 2025 16:31 ET  | Source: ImPact Biotech – Previously inoperable…
Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri
June 05, 2025 16:30 ET Â | Source: Vireo Growth Inc. MINNEAPOLIS ,…